Clinical Trials Logo

Clinical Trial Summary

Recruitment for prevention, and early detection among health disparities populations represents a major challenge in chronic disease control. This effect is magnified for individuals at high risk for conditions such as genetic breast cancer or chronic hepatitis. Costs are typically high, particularly given the common practice of developing a single outreach channel to address each disease or condition. In a randomized delayed intervention control trial, the investigators tested a strategy to identify low-income women at high risk for hereditary breast and ovarian cancer (HBOC) outside the clinical setting and refer them to free genetic counseling.


Clinical Trial Description

This study addresses a disparity in services related to the rare but serious condition of HBOC. In a randomized delayed intervention control trial, the investigators were able to identify high-risk but predominantly unaffected women among callers seeking referrals to free cancer screening. The investigators compared an immediate offer of a genetic counseling appointment to information on hereditary breast and ovarian cancer sent by mail. Our study demonstrated that when a diverse population of low-income women calls a trusted information and referral source, it is possible to both engage them on a topic that is different from the purpose for their call and to recruit them for participation in research. Our intervention was designed to fit as seamlessly as possible with two end user organizations. Existing staff (Information Specialists) of the state's phone service administered a simple family history screener similar to their usual procedure for assessing eligibility for free mammography. Cancer Risk Program Genetic Counseling Assistants followed up with an outcall, just as they do normally in response to family history screeners filled out in the hospital's mammography clinic. Our results not only showed a significantly larger effect on use of genetic counseling with the call and appointment offer compared with a mailed brochure, it was clear from calls made to women in both arms after the intervention period that calling is not only effective but essential to encourage use of genetic counseling in this population. The number of women counseled in the intervention group was initially much higher than the control group, and additional intervention group members obtained counseling when called again after the two month intervention period. The addition of genetic counseling by phone enabled a substantial number of women to obtain counseling who would not have done so otherwise. Our study demonstrated that, for the complex and highly personal issue of HBOC, multiple attempts over a period of months are needed and justified. ;


Study Design


Related Conditions & MeSH terms

  • Hereditary Breast and Ovarian Cancer Syndrome

NCT number NCT02956681
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase N/A
Start date October 2007
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT00535119 - Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer Phase 1
Recruiting NCT03294343 - Risk-Reducing Surgeries for Hereditary Ovarian Cancer N/A
Completed NCT00305695 - Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries Phase 2
Active, not recruiting NCT03832985 - Pediatric Reporting of Adult-Onset Genomic Results Early Phase 1
Active, not recruiting NCT02760849 - Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations N/A
Recruiting NCT02653105 - Women at Risk of Breast Cancer and OLFM4 N/A
Completed NCT01367639 - Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers Phase 2
Completed NCT02562170 - Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study Phase 4
Recruiting NCT03162276 - Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers Phase 3
Not yet recruiting NCT01445275 - Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 N/A
Recruiting NCT03015376 - Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Enrolling by invitation NCT04197856 - Direct Information to At-risk Relatives N/A
Completed NCT03784859 - Tissue Expansion in Breast Reconstruction Without Drains
Completed NCT04544501 - Enhance the Use of Genetic Counseling and Testing in Latinas N/A
Completed NCT00609505 - Telemedicine vs. Face-to-Face Cancer Genetic Counseling N/A
Terminated NCT02705924 - Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk N/A
Completed NCT01333748 - Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer Phase 2
Completed NCT00892736 - Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy Phase 1
Recruiting NCT05677048 - Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention N/A